Metraipolis › archive › dc_64e24fe8bed6
Evaluation of trimetazidine in alleviating paclitaxel-induced peripheral neuropathy in breast cancer patients: a randomized controlled trial — Europe PMC PMID:41704280
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41704280
- DOI
- 10.3389/fphar.2026.1748399
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T04:34:23.589Z
- SHA-256 of the archived text
6403e4a4417ea26c65183132e8b690ab10e8fe5ee9d00479ade3fa5606974292- Stable URL of this page
https://metraipolis.com/documento/dc_64e24fe8bed6
How to cite
Evaluation of trimetazidine in alleviating paclitaxel-induced peripheral neuropathy in breast cancer patients: a randomized controlled trial — Europe PMC PMID:41704280 — Europe PMC (en), https://europepmc.org/article/MED/41704280 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_64e24fe8bed6 (Metraipolis archive dc_64e24fe8bed6, sha256 6403e4a4417ea26c65183132e8b690ab10e8fe5ee9d00479ade3fa5606974292)
BibTeX
@misc{dc64e24fe8bed6,
title = {Evaluation of trimetazidine in alleviating paclitaxel-induced peripheral neuropathy in breast cancer patients: a randomized controlled trial — Europe PMC PMID:41704280},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41704280},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_64e24fe8bed6; sha256 6403e4a4417ea26c65183132e8b690ab10e8fe5ee9d00479ade3fa5606974292},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41704280. Agents can read the archived copy with the MCP tool read_document.